Kyverna Therapeutics Inc (KYTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Sales | 0 | 0 | 7,025 |
| Gross Profit | N/A | N/A | 7,025 |
| Operating Expenses | 142,604 | 62,406 | 36,409 |
| Operating Income | -142,604 | -62,406 | -29,384 |
| Interest Expense | 142 | 187 | 65 |
| Other Income | 15,269 | 2,227 | 556 |
| Pre-tax Income | -127,477 | -60,366 | -28,893 |
| Net Income Continuous | -127,477 | -60,366 | -28,893 |
| Net Income | $-127,477 | $-60,366 | $-28,893 |
| EPS Basic Total Ops | -3.33 | -89.61 | -63.43 |
| EPS Basic Continuous Ops | -3.33 | -89.56 | -63.43 |
| EPS Diluted Total Ops | -3.33 | -89.61 | -63.43 |
| EPS Diluted Continuous Ops | -3.33 | -89.56 | -63.43 |
| EPS Diluted Before Non-Recurring Items | -3.33 | -89.61 | -63.43 |
| EBITDA(a) | $-140,471 | $-60,699 | $-28,333 |